NICE medical technologies guidance: aims for clinical practice

Area of Science:

• Health Technology Assessment
• Medical Device Evaluation
• Health Economics

Background:

• The National Institute for Health and Care Excellence (NICE) provides guidance on medical technologies to the NHS.
• Established in 1999, NICE's Medical Technologies Evaluation Programme (MTEP) began in 2009.
• MTEP assesses if new devices offer improved patient benefits or cost savings compared to current practices.

Discussion:

• NICE evaluates single medical products to streamline the assessment process.
• This single-product approach aims to reduce manufacturer waiting times for guidance.
• The evaluation focuses on clinical benefits and economic value.

Key Insights:

• Sparse and low-quality research often hinders the evaluation of new medical devices.
• Lack of robust evidence is a primary reason for NICE rejecting products for assessment.
• Manufacturers must provide strong evidence of a technology's benefits and cost-effectiveness.

Outlook:

• Improving the quality and regulation of research for medical devices is crucial.
• Enhanced evidence generation could increase the number of technologies accepted for NICE evaluation.
• This could lead to faster adoption of beneficial innovations within the NHS.